Older individuals are at an increased risk for cardiac autonomic nervous dysfunction…

A multinational team of researchers studied data from over 16,000 patients in the SAVOR-TIMI 53 trial…. Saxagliptin (Onglyza) is a commonly prescribed dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes. An international team of researchers examined the effects of saxagliptin on glycemic stability and β-cell function in the …

But the association with between hypertension, diabetes, and dementia is not clear…. Previous studies have found a correlation between individuals with hypertension and diabetes, and the subsequent development of dementia. The purpose of this cross-sectional study was to analyze the effect of diabetes and hypertension on cognitive scores conducted on …

Initial combination therapy of metformin, pioglitazone, and exenatide might be more effective in reducing HbA1c compared to sequential add-on in new-onset diabetic patients… The purpose of this study is to initiate a therapy regimen that will reduce HbA1c, increase insulin secretion, and increase insulin sensitivity. This therapy will also avoid …

Study participants with untreated diabetes were significantly more likely to be male, older, currently smoking, have lower HDL cholesterol levels, higher BMI, non-HDL cholesterol levels, and systolic blood pressure….

Does screening help reduce the risk of cardiovascular disease for type 2 diabetes patients?… Previous studies have shown that diabetes screening can reduce the risk of cardiovascular disease (CVD) and myocardial infarction. In addition, diabetes screening also helps in detecting and changing unhealthy behaviors. However, self-rated health is often overlooked …

Human embryonic stem cell therapy was recently shown to reverse type 1 diabetes in mice, and now new mouse studies suggest a role for stem cells in the treatment of type 2 diabetes… Obese, diabetic mice treated with a combination of transplanted stem cell-derived pancreatic progenitor cells and insulin-sensitizing drugs …

Sitagliptin/Simvastatin (Juvisync) might be a good option for diabetic patients who want to improve glycemic control and lower cholesterol levels…

Diabetes can have an impact on life expectancy and health expenditures…

There might be an association between obesity with incidence of stroke among type 2 diabetic patients… Diabetes mellitus and obesity are the most common conditions that increase the risk of stroke in the general population. However, not many studies focused on the association between obesity and cardiovascular disease risk among …